Tuesday, February 10, 2026
Tuesday, February 10, 2026
HomeBREAKING NEWSRussia’s mRNA Cancer Vaccine Enteromix Shows 100% Efficacy in Clinical Trials

Russia’s mRNA Cancer Vaccine Enteromix Shows 100% Efficacy in Clinical Trials

Published on

In what scientists are calling a potential medical breakthrough, Russia’s mRNA-based cancer vaccine Enteromix has demonstrated 100% efficacy and safety in clinical trials. The vaccine, which targets and destroys cancer cells while shrinking large tumours, is now awaiting final approval from the Ministry of Health before being made available to the public, according to RT India.

Developed with technology similar to COVID-19 vaccines, Enteromix works by training the immune system to recognize and eliminate cancer cells. Remarkably, the vaccine is personalized for every patient, ensuring precise treatment.

Russia’s Enteromix Cancer Vaccine Shows 100% Success in Trials

Unlike chemotherapy or radiation, Enteromix did not cause any serious side effects, with patients reportedly tolerating the vaccine well. Earlier clinical trials involved 48 volunteers, overseen by Russia’s Ministry of Health’s National Medical Research Radiology Centre in collaboration with the Engelhardt Institute of Molecular Biology (EIMB) of the Russian Academy of Sciences (RAS).

Enteromix Unveiled at St. Petersburg Economic Forum

The clinical trial was officially announced at the St. Petersburg International Economic Forum (SPIEF 2025), held from June 18–21. Organized by the Roscongress agency under the Russian President’s office, the event highlighted Russia’s progress in biotechnology and advanced medical research.

How Enteromix Works Against Cancer

According to a MedPath report, Enteromix uses four harmless viruses to attack and destroy cancerous tumours, while simultaneously boosting the immune system to fight the disease. After years of testing, results have shown it can slow tumour growth and, in some cases, completely eradicate cancer cells.

Awaiting Final Approval Before Global Rollout

With trials successfully completed, the only step remaining is regulatory clearance from the Russian Ministry of Health. If approved, Enteromix could become the world’s first personalized mRNA cancer vaccine, offering new hope to millions of patients worldwide.

Get Latest News Live on MTIMES along with Breaking News and Top Headlines, Political News and around The World.

You May Like

Trending Searches Today |

Congress Criticises Government’s GST Reform, Says True GST 2.0 Reform in India Still Awaited

SSC CGL New Exam Date 2025 Out: Tier 1 Scheduled from 12th to 26th September

OSSSC Re-Conducts Preliminary Exam 2023: RI, ARI, Amin, Supervisor and SFS Posts from October 8

56th GST Council Meeting: Big GST Rate Cuts Announced, Focus on Common Man and Key Sectors

Vladimir Putin Backs India and China: “You Cannot Talk to India, China Like That” Amid Trump’s Tariff Pressure

Undersea Cable Cuts in Red Sea Disrupt Internet Across Asia and Middle East

Bestseller #1
  • DYNAMIC ISLAND COMES TO IPHONE 15 — Dynamic Island bubbles up alerts and Live Activities — so you don’t miss them while …
  • INNOVATIVE DESIGN — iPhone 15 features a durable color-infused glass and aluminum design. It’s splash, water, and dust r…
  • 48MP MAIN CAMERA WITH 2X TELEPHOTO — The 48MP Main camera shoots in super-high resolution. So it’s easier than ever to t…
₹59,700
Bestseller #2
  • 15 cm (6.1-inch) Super Retina XDR display
  • Cinematic mode adds shallow depth of field and shifts focus automatically in your videos
  • Advanced dual-camera system with 12MP Wide and Ultra Wide cameras; Photographic Styles, Smart HDR 4, Night mode, 4K Dolb…
₹60,900
Bestseller #3
  • BUILT FOR APPLE INTELLIGENCE — Apple Intelligence is the personal intelligence system that helps you write, express your…
  • TAKE TOTAL CAMERA CONTROL — Camera Control gives you an easier way to quickly access camera tools, like zoom or depth of…
  • GET FURTHER AND CLOSER — The improved Ultra Wide camera with autofocus lets you take incredibly detailed macro photos an…
₹83,500

Share Market

DIIs Overtake FIIs in Nifty50 Ownership for First Time

DIIs overtake FIIs in Nifty50 ownership for the first time, signalling a structural shift in India’s equity markets. Read why it matters.

Indian Equity Markets Close Higher After RBI Outlook

Indian equity markets close higher as RBI lifts growth outlook for H1 FY27. Sensex, Nifty end week positive. Read the market cues.

More like this

Network Readiness Index 2025 India Climbs Four Spots to Rank 45th Globally

Network Readiness Index 2025 India rising to 45th rank globally with gains in AI, telecom investment and ICT exports. Read full report

Odisha Paddy Procurement Crisis: Naveen Patnaik Accuses Govt of Betraying Farmers

Odisha paddy procurement crisis deepens as Patnaik accuses government of broken MSP promises, mandi exploitation and payment delays.

Scotland vs Italy T20 World Cup: Munsey Powers 73-Run Win

Italy National Cricket Team Match Scorecard Vs Scotland National Cricket Team Scotland vs Italy T20 World Cup opener sees Scotland